Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricide.
Saved in:
| Title: | Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricide. |
|---|---|
| Authors: | Dobson, Lachlan J1 (AUTHOR), Hock, Barry D2,3 (AUTHOR), Drabble, Ariana HT1 (AUTHOR), Goddard, Liping2,3 (AUTHOR), McKenzie, Judith L2,3 (AUTHOR), MacPherson, Sean A2,3 (AUTHOR), McLellan, Alexander D1,4 (AUTHOR) alex.mclellan@otago.ac.nz |
| Source: | Clinical & Translational Immunology. May2026, Vol. 15 Issue 5, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 194055797 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricide. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Dobson%2C+Lachlan+J%22">Dobson, Lachlan J</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hock%2C+Barry+D%22">Hock, Barry D</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Drabble%2C+Ariana+HT%22">Drabble, Ariana HT</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goddard%2C+Liping%22">Goddard, Liping</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McKenzie%2C+Judith+L%22">McKenzie, Judith L</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22MacPherson%2C+Sean+A%22">MacPherson, Sean A</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McLellan%2C+Alexander+D%22">McLellan, Alexander D</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> alex.mclellan@otago.ac.nz</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Translational+Immunology%22">Clinical & Translational Immunology</searchLink>. May2026, Vol. 15 Issue 5, p1-10. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194055797 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cti2.70098 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1 Titles: – TitleFull: Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricide. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dobson, Lachlan J – PersonEntity: Name: NameFull: Hock, Barry D – PersonEntity: Name: NameFull: Drabble, Ariana HT – PersonEntity: Name: NameFull: Goddard, Liping – PersonEntity: Name: NameFull: McKenzie, Judith L – PersonEntity: Name: NameFull: MacPherson, Sean A – PersonEntity: Name: NameFull: McLellan, Alexander D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 20500068 Numbering: – Type: volume Value: 15 – Type: issue Value: 5 Titles: – TitleFull: Clinical & Translational Immunology Type: main |
| ResultId | 1 |